Company intelligence / Profile preview

Blueberry Diagnostics

Wilmington, Delaware, United Statesblueberrydx.com ↗

Ownership: Private
Development stage: Commercial

Overview

Blueberry Diagnostics has developed a portfolio of minimally invasive diagnostic tests powered by proprietary AI/machine learning algorithms. These tests use routine blood and urine analyses to enable early detection of cancers with high accuracy. Their solutions have been validated in peer-reviewed journals such as JCO, Annals of Oncology, and JTO, with presentations at major conferences including ASCO, WCLC, and ESMO. Products include Sx Preventive Colon for colon cancer screening before symptoms appear.

Therapeutic areas: Oncology
Modalities: Diagnostic test
Industry: Molecular Diagnostics

Partnerships

Cloud Health Ventures Inc.Bioprognos Inc.Kience Inc.

Beyond the preview

Go deeper on Blueberry Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blueberry Diagnostics.

Explore the full profile